{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:54:32Z","timestamp":1791464072307,"version":"4.3.4"},"reference-count":132,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"National Recovery and Resilience Plan"},{"name":"European Union \u2013 NextGeneration EU","award":["2022HXMY4P"],"award-info":[{"award-number":["2022HXMY4P"]}]},{"name":"Italian Ministry of University and Research"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/13543776.2026.2633345","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:24:31Z","timestamp":1771302271000},"page":"363-387","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Patents involving monoamine oxidase (MAO): a comprehensive update (2022\u20132025) on its inhibitors and applications"],"prefix":"10.1080","volume":"36","author":[{"given":"Moataz A.","family":"Shaldam","sequence":"first","affiliation":[{"name":"Kafrelsheikh University","place":["Kafrelsheikh, Egypt"]},{"name":"\u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":false,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[{"name":"\u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Balaha","sequence":"additional","affiliation":[{"name":"Kafrelsheikh University","place":["Kafrelsheikh, Egypt"]},{"name":"\u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-6925","authenticated-orcid":false,"given":"Paolo","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Diomede","sequence":"additional","affiliation":[{"name":"\u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-7326","authenticated-orcid":false,"given":"Ilaria","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham O.","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Tanta University","place":["Tanta, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2083501"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1427735"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-2803-5_26"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115188"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00143"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.676239"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05192-w"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3017947"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1915-z"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121688"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/md17060377"},{"issue":"1","key":"e_1_3_5_14_1","first-page":"1","article-title":"Advances of AI-driven drug design and discovery in pharmaceuticals-review","volume":"8","author":"Pandey DR","year":"2024","unstructured":"Pandey DR, Dash SS, Mishra A. Advances of AI-driven drug design and discovery in pharmaceuticals-review. J Angiother. 2024;8(1):1\u201310.","journal-title":"J Angiother"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-7757-9_5"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450122666210707120256"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.baga.2012.04.032"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28124814"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207320666170310121337"},{"key":"e_1_3_5_20_1","volume-title":"Polypharmacology: strategies for multi-target drug discovery","author":"Peters J-U","year":"2024","unstructured":"Peters J-U. Polypharmacology: strategies for multi-target drug discovery. Hoboken, NJ, USA: John Wiley & Sons; 2024."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/7355_2022_154"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900016965"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2174\/156802612805220011"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207323666200402090557"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3334-z"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852922000906"},{"issue":"1","key":"e_1_3_5_27_1","first-page":"E22115560349319","article-title":"Precision medicine and antipsychotics in parkinson\u2019s disease: a focus on MAO-B pathway modulation","volume":"13","author":"Kumaraswamy P","year":"2025","unstructured":"Kumaraswamy P, Dubey S, Tiwari P. Precision medicine and antipsychotics in parkinson\u2019s disease: a focus on MAO-B pathway modulation. Curr Psychopharmacol. 2025;13(1):E22115560349319.","journal-title":"Curr Psychopharmacol"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104707"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673264076230921065945"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.09.010"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.04.003"},{"key":"e_1_3_5_32_1","unstructured":"Deshwal S. Mitochondrial ROS formation catalyzed by monoamine oxidase is causally related to inflammation fibrosis and diastolic dysfunction in type 1 diabetic hearts. 2017."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24102005"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c04100"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03219-y"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/156802612805219996"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207320666170414102814"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.3c00573"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules191118936"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020280"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2009.12.019"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200106155127"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2020.1790618"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.90621"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-658-47121-7_14"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.132244"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2022.68.11.2"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.02.005"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112993"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.2174\/0113895575392491250630195630"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm7009364"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-020-10155-6"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.15.12.1763"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2010.495716"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.698613"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.982535"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2023.2226860"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.982535"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1637415"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_5_61_1","unstructured":"Ellison Institute. Monoamine oxidase inhibitors. WO 2024\/229078 A1. 2024."},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01097-4"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00408-4"},{"key":"e_1_3_5_64_1","unstructured":"Neurobiogen Co. Ltd. Phenylamino propanamide derivative and pharmaceutical composition comprising same. WO 2025\/095651 A1. 2025."},{"key":"e_1_3_5_65_1","unstructured":"Enveric Biosciences Canada Inc. C4-Carboxylic acid-substituted tryptamine derivatives and methods of using. WO 2023\/173196 A1. 2023."},{"key":"e_1_3_5_66_1","unstructured":"Enveric biosciences Canada Inc. Salts of C4-carboxylic acid- and C4-carbonothioate-substituted tryptamine derivatives and methods of using. WO 2023\/173229 A1. 2023."},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.05.039"},{"key":"e_1_3_5_68_1","unstructured":"Dale AV. Novel isaindigotone inspired derivatives as potent multitarget ligands for Alzheimer\u2019s disease. IN 2024\/21073399 a. 2024."},{"key":"e_1_3_5_69_1","unstructured":"Miralogx LLC. Synthetic cannabinold compounds pharmaceutical compositions and treatment methods. WO 2023\/096918 A1. 2023."},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867331666230913100624"},{"key":"e_1_3_5_71_1","unstructured":"Nanjing Medical University. Selective monoamine oxidase B inhibitor and pharmaceutical use thereof. WO 2025\/030709 A1. 2025."},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.2174\/156802612805220057"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986711797636090"},{"key":"e_1_3_5_74_1","unstructured":"The Maharaja Sayajirao University of Baroda. Novel N-(2-(3 4-diaryl-1H-pyrazole-1-carboxamido)ethyl)-1-substituted benzylpiperidine-4-carboxamide as potential anti-alzheimer\u2019s agents and the process of their preparation. IN 2024\/21095741 a. 2024."},{"key":"e_1_3_5_75_1","unstructured":"The Maharaja Sayajirao University of Baroda. Novel substituted 2-(3 4-diaryl-1H-pyrazole-1-carboxamido)ethyl)carbamate as potential anti-Alzheimer\u2019s agents and the process of their preparation. IN 2025\/21005283 a. 2025."},{"key":"e_1_3_5_76_1","unstructured":"Dayananda Sagar University. Synthesis of novel pyrazole derivatives for treatment of depression. IN 2025\/41007634 a. 2025."},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273340983241018095529"},{"key":"e_1_3_5_78_1","unstructured":"Institute of Materia Medica of CAMS and PUMC Benzyloxyaryl compounds and preparation methods pharmaceutical compositions and uses thereof. CN 117658885 A. 2024."},{"key":"e_1_3_5_79_1","unstructured":"Guangdong HEC Pharmaceutical. Pyrrolidine amide derivatives and use thereof. CN 118063445 A. 2024."},{"key":"e_1_3_5_80_1","unstructured":"Hainan Inrui Biopharmaceutical Technology Co. Ltd. Biphenyl tetrahydropyrrole compound preparation method therefor and use thereof. WO 2025\/073270 A1. 2025."},{"key":"e_1_3_5_81_1","unstructured":"University of California San Diego. Radiolabelled and nonradiolabelled pegylated compounds and uses thereof. US 2022\/0008563 A1. 2022."},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1408"},{"key":"e_1_3_5_83_1","unstructured":"Amrita School of Pharmacy. Unsubstituted or halogen substituted hydrazone-based isatin compounds as potent MAO-B inhibitors. IN 2023\/41023176 a. 2023."},{"key":"e_1_3_5_84_1","unstructured":"Bahcesehir Universitesi. A novel MAO-B inhibitor DRG-MAOB-1 for use in treatment of neurodegenerative diseases. US 2023\/0093302 A1. 2023."},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026622666220225152443"},{"key":"e_1_3_5_86_1","unstructured":"Univerza V Ljubljani. Quinolin-2-yl nitrones useful for the prevention and\/or treatment of neurodegenerative diseases. EP 4269393 A1. 2023."},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.21461"},{"key":"e_1_3_5_88_1","unstructured":"Central University of Punjab. 2-Aryl quinazoline\/quinazolinone derivatives based multi-targeting agents for treating neurological disorders and method for prepration thereof. IN 2023\/11052944 a. 2023."},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106441"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105130"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127188"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871524918666180426125714"},{"key":"e_1_3_5_93_1","unstructured":"China Pharmaceutical University. Nitrocatechol derivative pharmaceutical composition containing nitrocatechol derivative and application of nitrocatechol derivative. CN 116283664 A. 2025."},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c01470"},{"key":"e_1_3_5_95_1","unstructured":"Kunming Institute of Botany of CAS. Benzyl alkene pitches benzene peptides and its pharmaceutical composition and its application. CN 108752300 A. 2022."},{"key":"e_1_3_5_96_1","unstructured":"Institute of Materia Medica of CAMS and PUMC. Isobenzofuran-1(3H)-one compounds and preparation methods pharmaceutical compositions and uses thereof. CN 118930552 A. 2024."},{"key":"e_1_3_5_97_1","unstructured":"Institute of Materia Medica of CAMS and PUMC. 5 6 7 8-tetrahydrofuran[3 4-g]isoquinolin-3(1H)-one compound and preparation method pharmaceutical composition and use thereof. CN 118930553 A. 2024."},{"key":"e_1_3_5_98_1","unstructured":"Hangzhou Normal University. HDAC\/MAO-B dual inhibitor preparation thereof and application thereof. WO 2023\/061101 A1. 2023."},{"key":"e_1_3_5_99_1","unstructured":"Yonsei University Industry-Academic Cooperation. Synthetic peptides capable of functioning as dopamine-like mimotope and MAO-B inhibitor. KR 102790040 B1. 2025."},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-013-9490-6"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105831"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103043"},{"key":"e_1_3_5_103_1","unstructured":"Suncheon National University Industry-Academic Cooperation Foundation and Myongji University Industry-Academic Cooperation Foundation. Composition for preventing or treating neurodegenerative disease comprising macelignan compounds derived from natural plants. KR 102465808 B1. 2022."},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070847"},{"key":"e_1_3_5_105_1","unstructured":"Suncheon National University Industry-Academic Cooperation Group. Composition for preventing or treating neurodegenerative disease comprising chalcone derivatives. KR 102545193 B1. 2023."},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/pr11102919"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu17111939"},{"key":"e_1_3_5_108_1","unstructured":"Lovely Professional University. A solid lipid nanoparticles mediated nose to brain delivery of selegiline and brahmi extract for parkinson\u2019s disease. IN 2022\/11074478 a. 2022."},{"key":"e_1_3_5_109_1","unstructured":"Mycrodose Therapeutics Inc. Transdermal system formulation and method for the therapeutic administration of a psychedelic agent. WO 2022\/212789 A1. 2022."},{"key":"e_1_3_5_110_1","unstructured":"Biomind Labs Inc. Dimethyltriptamine-based nasal spray for the personalised treatment of neurological and psychiatric disorders. US 2023\/0094051 A1. 2023."},{"key":"e_1_3_5_111_1","unstructured":"Natural MedTech Pty Ltd. Tryptamine formulations and uses thereof. WO 2024\/098098 A1. 2024."},{"key":"e_1_3_5_112_1","unstructured":"Modern College of Pharmacy (for Ladies) Moshi and Annasaheb Dange College of D Pharmacy Ashta. Novel formulation of rasagiline mesylate restraining transdermal patches. IN 2022\/21015302 a. 2022."},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108471"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1068162023020139"},{"key":"e_1_3_5_115_1","unstructured":"Jogani J. Methods and compositions for treating cdkl5 disorder using monoamine oxidase inhibitors. US 2025\/0127766 A1. 2025."},{"key":"e_1_3_5_116_1","unstructured":"Neurawell Therapeutics. Combination treatments for depression and other disorders. WO 2024\/259412 A2. 2024."},{"key":"e_1_3_5_117_1","unstructured":"University of California San Diego UCSD. Monoamine oxidase blockade therapy for treating cancer through regulating antitumor T cell immunity. US 2023\/0390220 A1. 2023."},{"key":"e_1_3_5_118_1","unstructured":"Vestlandets Innovasjonsselskap As. NAD-augmentation therapy for parkinson\u2019s disease. WO 2022\/269064 A1. 2022."},{"key":"e_1_3_5_119_1","unstructured":"Sintalica SRL. Composition comprising tryptamines and maois compounds selected from \u03b2-carboline inhibitors and pharmaceutical uses thereof. WO 2024\/079647 A1. 2024."},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00375"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38410-y"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614040-00002"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00340"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-9158-1-10"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojmc.2019.91001"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2016.02.013"},{"key":"e_1_3_5_127_1","unstructured":"Korea Advanced Institute of Science and Technology KAIST. Antisense oligomers against monoamine oxidase B and use thereof. EP 4534671 A1. 2025."},{"key":"e_1_3_5_128_1","unstructured":"University Of Southern California. Methods compositions for treatment biomarkers and diagnosis for colorectal cancer. WO 2024\/206503 A2. 2024."},{"key":"e_1_3_5_129_1","unstructured":"Trustees Of Boston University. Monoamine oxidase (MAO) electrochemical biosensor and uses thereof. WO 2024\/081853 A3. 2024."},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871524915666150831141705"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2465"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.07.002"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.02.020"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286848"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2633345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:35:09Z","timestamp":1775039709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2633345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/13543776.2026.2633345"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2633345","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}